Literature DB >> 17961190

Monoclonal B-cell lymphocytosis in blood donors.

Jane M Rachel1, Marjorie L Zucker, Christopher M Fox, Fred V Plapp, Jay E Menitove, Fatima Abbasi, Gerald E Marti.   

Abstract

Monoclonal B-cell populations have been detected in the peripheral blood of apparently healthy individuals by flow cytometry. In 2005, the term monoclonal B-cell lymphocytosis (MBL) was proposed to describe these findings. MBL may be immunophenotypically similar to chronic lymphocytic leukaemia (CLL) and, like CLL, the prevalence is higher in males and older individuals. We studied the prevalence of MBL in blood donors from the Midwestern United States. Samples from 5141 donors were examined and seven (0.14%) were found to have immunophenotypic characteristics of MBL or CLL. Immunoglobulin heavy chain analysis yielded monoclonality or oligoclonality. Prior and subsequent to the study, an additional undetermined number of blood donors were screened and seven of these expressed immunophenotypic characteristics of MBL or CLL. We thus found a total of 14 healthy blood donors with monoclonal expansions of B-lymphocyte populations. Of these, 12 were presumptively classified as MBL and two as CLL. All but two of the donors were male; the mean age was 59 years. The clinical importance of these findings with regard to transfusion medicine has not been established.

Entities:  

Mesh:

Year:  2007        PMID: 17961190     DOI: 10.1111/j.1365-2141.2007.06870.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  15 in total

Review 1.  Prevalence of monoclonal B-cell lymphocytosis: a systematic review.

Authors:  Youn K Shim; Dannie C Middleton; Neil E Caporaso; Jane M Rachel; Ola Landgren; Fatima Abbasi; Elizabeth S Raveche; Andy C Rawstron; Alberto Orfao; Gerald E Marti; Robert F Vogt
Journal:  Cytometry B Clin Cytom       Date:  2010       Impact factor: 3.058

2.  Monoclonal B-cell lymphocytosis in healthy blood donors: an unexpectedly common finding.

Authors:  Youn K Shim; Jane M Rachel; Paolo Ghia; Jeff Boren; Fatima Abbasi; Antonis Dagklis; Geri Venable; Jiyeon Kang; Heba Degheidy; Fred V Plapp; Robert F Vogt; Jay E Menitove; Gerald E Marti
Journal:  Blood       Date:  2013-12-17       Impact factor: 22.113

Review 3.  Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management.

Authors:  T D Shanafelt; P Ghia; M C Lanasa; O Landgren; A C Rawstron
Journal:  Leukemia       Date:  2010-01-21       Impact factor: 11.528

Review 4.  Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification.

Authors:  Paolo Strati; Tait D Shanafelt
Journal:  Blood       Date:  2015-06-11       Impact factor: 22.113

Review 5.  Precursors to lymphoproliferative malignancies.

Authors:  Lynn R Goldin; Mary L McMaster; Neil E Caporaso
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04       Impact factor: 4.254

Review 6.  Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL).

Authors:  Andy C Rawstron; Tait Shanafelt; Mark C Lanasa; Ola Landgren; Curtis Hanson; Alberto Orfao; Peter Hillmen; Paolo Ghia
Journal:  Cytometry B Clin Cytom       Date:  2010       Impact factor: 3.058

7.  Allogeneic transplantation for chronic lymphocytic leukemia.

Authors:  Luca Laurenti; Michela Tarnani; Patrizia Chiusolo; Federica Sorà; Simona Sica
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-09-07       Impact factor: 2.576

Review 8.  Hematopoietic stem cell aging and chronic lymphocytic leukemia pathogenesis.

Authors:  Yoshikane Kikushige; Toshihiro Miyamoto
Journal:  Int J Hematol       Date:  2014-08-07       Impact factor: 2.490

9.  Prevalence of monoclonal B lymphocytosis in first-degree relatives of chronic lymphocytic leukemia patients in Turkey.

Authors:  Taner Demirci; Zeynep Arzu Yeğin; Nevruz Kurşunoğlu; Zeynep Yılmaz; Elif Suyanı; Zübeyde Nur Özkurt; Münci Yağcı
Journal:  Turk J Haematol       Date:  2015-03-05       Impact factor: 1.831

Review 10.  Pathophysiology of chronic lymphocytic leukemia and human B1 cell development.

Authors:  Yoshikane Kikushige
Journal:  Int J Hematol       Date:  2019-12-03       Impact factor: 2.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.